Geisinger on Routine Sequencing
July 17, 2018 | Terry Sharrer
“Precision medicine” based on DNA sequencing is all the buzz in healthcare except among payers who deem molecular profiling “experimental.” However, Geisinger Healthcare (Danville, PA) has announced a pilot program to do routine sequencing on 1,000 patients, aiming at disease prevention. Geisinger expects between ten and fifteen percent of these patients will benefit from the screening, which surely will be good news for them, but not so much as an incentive to insurers. MORE
Image Credit: Flickr